Ozekibart meets its primary endpoint in chondrosarcoma, demonstrating a statistically significant and clinically meaningful improvement in median ...

Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with ...

Ofirnoflast (HT-6184) is Halia Therapeutics' lead investigational compound and a first-in-class NEK7 modulator that regulates activation of the NLRP3 inflammasome — an upstream molecular complex ...

Sundowner syndrome is becoming a frequent description of aging dogs. It describes elderly dogs that have a pattern of ...

An international research team has determined the first high-resolution structures of the herpes simplex virus origin-binding ...

LOS ANGELES, CALIFORNIA / ACCESS Newswire / October 23, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of ...

When a planarian flatworm loses its head, it simply grows another. The head, if left alone, can grow a body to match. In a ...

Ooops... Something went wrong while loading this page.

Cellarity, a biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today announced the publication of a seminal manuscript in the journal ...

Shendure directs the Allen Discovery Center for Cell Lineage at the Allen Institute and the Brotman Baty Institute for ...

Cellarity, a biotechnology company developing cell state-correcting therapies through integrated multi-omics and AI modeling, ...